Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

10X Genomics

Explore full profile

Building tools for scientific discovery that reveal and address the true complexities of biology and disease

Pleasanton, United StatesFounded 2012Biotech & Life Sciences
Valuation $5.54B Market cap · Aug/2026
Revenue $614M Latest reported FY

At a glance

Status
Listed
Founded
2012
Headquarters
Pleasanton, United States
Listing
IPO 2019
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom
News Cathie Wood's ARK buys $28M in Cerebras, trims Palantir and Shopify Aug 14, 2026

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later10 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 2,413 incl. 8 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 10 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 10 startups shown

Former 10X Genomics employees who went on to found companies, sorted by Dealroom signal score.

MoleculentEst. 2021
Olle EricssonSweden
Signal score93
PixelgenEst. 2020
Alvaro Martinez BarrioSweden
Signal score90
InfinimmuneEst. 2022
MGMichael GibbonsUnited States
Signal score77
CubaseBioEst. 2024
Xiaoyan QianSweden
Signal score75
OmniscopeEst. 2021
VVVijay VaswaniSpain
Signal score73
5 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
34 countries with
team presence
🇺🇸 United States74.1%
🇸🇬 Singapore5.9%
🇬🇧 United Kingdom3.1%
🇳🇱 Netherlands3%
🇩🇪 Germany2.4%
Top 5 of 34 shown
Web traffic by country
400K monthly visits
across markets
🇮🇹 Italy23.6%
🇺🇸 United States22.1%
🏳️ Korea6%
🏳️ Republic of4.9%
🇫🇷 France4.3%
Top 5 markets shown

Patents

Estimated portfolio value
$254M

578 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where 10X Genomics was the backer or acquirer, 2018–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across 10X Genomics's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where 10X Genomics deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        10X Genomics's portfolio, mapped.

        Stage
        Period
        6 of 6 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about 10X Genomics on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See 10X Genomics on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles